These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 34750517)
1. Cancer biology and molecular genetics of A Mazziotta C; Rotondo JC; Lanzillotti C; Campione G; Martini F; Tognon M Oncogene; 2022 Jan; 41(3):301-308. PubMed ID: 34750517 [TBL] [Abstract][Full Text] [Related]
2. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations. Mlejnek P; Dolezel P; Frydrych I J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730 [TBL] [Abstract][Full Text] [Related]
3. A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway. Jafari SM; Panjehpour M; Aghaei M; Joshaghani HR; Enderami SE J Cell Biochem; 2017 Sep; 118(9):2909-2920. PubMed ID: 28230290 [TBL] [Abstract][Full Text] [Related]
4. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway. Ren T; Tian T; Feng X; Ye S; Wang H; Wu W; Qiu Y; Yu C; He Y; Zeng J; Cen J; Zhou Y Sci Rep; 2015 Mar; 5():9047. PubMed ID: 25762375 [TBL] [Abstract][Full Text] [Related]
5. A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition. Madi L; Bar-Yehuda S; Barer F; Ardon E; Ochaion A; Fishman P J Biol Chem; 2003 Oct; 278(43):42121-30. PubMed ID: 12865431 [TBL] [Abstract][Full Text] [Related]
6. Current Status in the Design and Development of Agonists and Antagonists of Adenosine A3 Receptor as Potential Therapeutic Agents. Mailavaram RP; Al-Attraqchi OHA; Kar S; Ghosh S Curr Pharm Des; 2019; 25(25):2772-2787. PubMed ID: 31333098 [TBL] [Abstract][Full Text] [Related]
8. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis. Lee J; Hwang I; Lee JH; Lee HW; Jeong LS; Ha H Am J Pathol; 2013 Nov; 183(5):1488-1497. PubMed ID: 24001475 [TBL] [Abstract][Full Text] [Related]
9. Chronic Morphine-Induced Changes in Signaling at the A Doyle TM; Largent-Milnes TM; Chen Z; Staikopoulos V; Esposito E; Dalgarno R; Fan C; Tosh DK; Cuzzocrea S; Jacobson KA; Trang T; Hutchinson MR; Bennett GJ; Vanderah TW; Salvemini D J Pharmacol Exp Ther; 2020 Aug; 374(2):331-341. PubMed ID: 32434943 [TBL] [Abstract][Full Text] [Related]
10. Species dependence of A Gao ZG; Auchampach JA; Jacobson KA Purinergic Signal; 2023 Sep; 19(3):523-550. PubMed ID: 36538251 [TBL] [Abstract][Full Text] [Related]
11. Extracellular adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A Torres Á; Erices JI; Sanchez F; Ehrenfeld P; Turchi L; Virolle T; Uribe D; Niechi I; Spichiger C; Rocha JD; Ramirez M; Salazar-Onfray F; San Martín R; Quezada C Cancer Lett; 2019 Apr; 446():112-122. PubMed ID: 30660649 [TBL] [Abstract][Full Text] [Related]
12. Molecular dissection of the human A Storme J; Cannaert A; Van Craenenbroeck K; Stove CP Biochem Pharmacol; 2018 Feb; 148():298-307. PubMed ID: 29309765 [TBL] [Abstract][Full Text] [Related]
13. Adenosine A Duangrat R; Parichatikanond W; Chanmahasathien W; Mangmool S Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891948 [TBL] [Abstract][Full Text] [Related]
14. Short- and long-term A3 adenosine receptor activation inhibits the Na+/H+ exchanger NHE3 activity and expression in opossum kidney cells. Di Sole F; Cerull R; Babich V; Casavola V; Helmle-Roth C; Burckhardt G J Cell Physiol; 2008 Jul; 216(1):221-33. PubMed ID: 18286509 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of DPTN and other selective A Gao ZG; Suresh RR; Jacobson KA Purinergic Signal; 2021 Dec; 17(4):737-746. PubMed ID: 34713378 [TBL] [Abstract][Full Text] [Related]
16. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors. Tian Y; Marshall M; French BA; Linden J; Yang Z Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314 [TBL] [Abstract][Full Text] [Related]
17. Generation of adenosine A3 receptor functionally humanized mice for the evaluation of the human antagonists. Yamano K; Inoue M; Masaki S; Saki M; Ichimura M; Satoh M Biochem Pharmacol; 2006 Jan; 71(3):294-306. PubMed ID: 16300745 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor. Wu W; He Y; Feng X; Ye S; Wang H; Tan W; Yu C; Hu J; Zheng R; Zhou Y Oncotarget; 2017 Jan; 8(1):705-721. PubMed ID: 27893428 [TBL] [Abstract][Full Text] [Related]
19. Cryo-EM structures of adenosine receptor A Cai H; Guo S; Xu Y; Sun J; Li J; Xia Z; Jiang Y; Xie X; Xu HE Nat Commun; 2024 Apr; 15(1):3252. PubMed ID: 38627384 [TBL] [Abstract][Full Text] [Related]
20. A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis. Lee HT; Kim M; Joo JD; Gallos G; Chen JF; Emala CW Am J Physiol Regul Integr Comp Physiol; 2006 Oct; 291(4):R959-69. PubMed ID: 16728466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]